Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial.
The objective of the study is to evaluate the safety and immunogenicity of the recombinant zoster vaccine (RZV) in patients with rheumatoid arthritis (RA) using abatacept. We randomised 70 participants to receive 2 doses of RZV or placebo 8 weeks apart. The primary immunologic e…